Sinopsis
New and exciting data presented each day during the conference and address the potential impact on current clinical practice.
Episodios
-
![Chemotherapy vs Novel Agents in Young CLL Patients: Is There Still a Role for Chemotherapy? - Neil E. Kay, MD]()
Chemotherapy vs Novel Agents in Young CLL Patients: Is There Still a Role for Chemotherapy? - Neil E. Kay, MD
31/12/2019 Duración: 16minFirst- and Second-Line Treatment Updates in CLL: The Role of Targeted Therapy
-
![Panel Discussion on CAR-T in Myeloma - James R. Berenson, MD Sham Mailankody, MBBS Deepu Madduri, MD Adam D. Cohen, MD]()
Panel Discussion on CAR-T in Myeloma - James R. Berenson, MD; Sham Mailankody, MBBS; Deepu Madduri, MD; Adam D. Cohen, MD
31/12/2019 Duración: 07minNew Immunological Approaches to Myeloma: CAR T-Cell Therapy and Other Novel Strategies
-
![CAR-Ts: What are the Next-Gen Products and Strategies? - Adam D. Cohen, MD]()
CAR-Ts: What are the Next-Gen Products and Strategies? - Adam D. Cohen, MD
31/12/2019 Duración: 21minNew Immunological Approaches to Myeloma: CAR T-Cell Therapy and Other Novel Strategies
-
![Dealing with Adverse Events and Toxicities in CAR-T cell Therapy - Deepu Madduri, MD]()
Dealing with Adverse Events and Toxicities in CAR-T cell Therapy - Deepu Madduri, MD
31/12/2019 Duración: 22minNew Immunological Approaches to Myeloma: CAR T-Cell Therapy and Other Novel Strategies
-
![Responses to CAR-T Therapy in Multiple Myeloma - Sham Mailankody, MBBS]()
Responses to CAR-T Therapy in Multiple Myeloma - Sham Mailankody, MBBS
31/12/2019 Duración: 17minNew Immunological Approaches to Myeloma: CAR T-Cell Therapy and Other Novel Strategies
-
![The Role of BCMA in Predicting Outcomes and Monitoring MM and CLL - James R. Berenson, MD]()
The Role of BCMA in Predicting Outcomes and Monitoring MM and CLL - James R. Berenson, MD
31/12/2019 Duración: 20minNew Immunological Approaches to Myeloma: CAR T-Cell Therapy and Other Novel Strategies
-
![Mantle Cell Lymphoma: New and Emerging Agents - Michael E. Williams, MD]()
Mantle Cell Lymphoma: New and Emerging Agents - Michael E. Williams, MD
31/12/2019 Duración: 19minMantle Cell Lymphoma: New and Emerging Agents
-
![Revolutionizing the R/R DLBCL Treatment Paradigm: Innovative, Strategic and Targeted Approaches - John P. Leonard, MD]()
Revolutionizing the R/R DLBCL Treatment Paradigm: Innovative, Strategic and Targeted Approaches - John P. Leonard, MD
31/12/2019 Duración: 20minRevolutionizing the R/R DLBCL Treatment Paradigm: Innovative, Strategic and Targeted Approaches
-
![Who Should Receive CAR-T Cell Therapy for Lymphoma - Craig S. Sauter, MD]()
Who Should Receive CAR-T Cell Therapy for Lymphoma - Craig S. Sauter, MD
31/12/2019 Duración: 21minTreatment for Marginal Zone Lymphoma: Should it be Different from FL?
-
![Panel Discussion: Marginal Zone Lymphoma - Thomas M. Habermann, MD and John P. Leonard, MD]()
Panel Discussion: Marginal Zone Lymphoma - Thomas M. Habermann, MD and John P. Leonard, MD
31/12/2019 Duración: 01minTreatment for Marginal Zone Lymphoma: Should it be Different from FL?
-
![Treatment for Marginal Zone Lymphoma: Should it be Different from Follicular Lymphoma? - Thomas M. Habermann, MD]()
Treatment for Marginal Zone Lymphoma: Should it be Different from Follicular Lymphoma? - Thomas M. Habermann, MD
31/12/2019 Duración: 19minTreatment for Marginal Zone Lymphoma: Should it be Different from FL?
-
![Who Should Receive CAR-T Cell Therapy for Lymphoma - Craig S. Sauter, MD]()
Who Should Receive CAR-T Cell Therapy for Lymphoma - Craig S. Sauter, MD
31/12/2019 Duración: 21minMoving Forward in the Treatment of Relapsed/Refractory Follicular Lymphoma
-
![Panel Discussion: Great Debates in Follicular Lymphoma - John P. Leonard, MD Carla Casulo, MD Bruce D. Cheson, MD Richard I. Fisher, MD Thomas M. Habermann, MD Peter Martin, MD]()
Panel Discussion: 'Great' Debates in Follicular Lymphoma - John P. Leonard, MD; Carla Casulo, MD; Bruce D. Cheson, MD; Richard I. Fisher, MD; Thomas M. Habermann, MD; Peter Martin, MD
31/12/2019 Duración: 08minMoving Forward in the Treatment of Relapsed/Refractory Follicular Lymphoma
-
![Debate: Chemotherapy no Longer Has a Major Role in the Treatment of Follicular Lymphoma - Bruce D. Cheson, MD and Richard I. Fisher, MD]()
Debate: Chemotherapy no Longer Has a Major Role in the Treatment of Follicular Lymphoma - Bruce D. Cheson, MD and Richard I. Fisher, MD
31/12/2019 Duración: 22minMoving Forward in the Treatment of Relapsed/Refractory Follicular Lymphoma
-
![Debate: Watch and Wait in Follicular Lymphoma: Should We Treat Immediately? - Peter Martin, MD and Carla Casulo, MD]()
Debate: Watch and Wait in Follicular Lymphoma: Should We Treat Immediately? - Peter Martin, MD and Carla Casulo, MD
31/12/2019 Duración: 33minMoving Forward in the Treatment of Relapsed/Refractory Follicular Lymphoma
-
![Panel Discussion on Great Debates in Follicular Lymphoma - John P. Leonard, MD Carla Casulo, MD Bruce D. Cheson, MD Richard I. Fisher, MD Thomas M. Habermann, MD Peter Martin, MD]()
Panel Discussion on 'Great' Debates in Follicular Lymphoma - John P. Leonard, MD; Carla Casulo, MD; Bruce D. Cheson, MD; Richard I. Fisher, MD; Thomas M. Habermann, MD; Peter Martin, MD
31/12/2019 Duración: 08minMoving Forward in the Treatment of Relapsed/Refractory Follicular Lymphoma: Understanding the PI3K Inhibitors
-
![Debate: Does Chemotherapy Still Have a Major Role to Play in the Treatment of FL? - Bruce D. Cheson, MD and Richard I. Fisher, MD]()
Debate: Does Chemotherapy Still Have a Major Role to Play in the Treatment of FL? - Bruce D. Cheson, MD and Richard I. Fisher, MD
31/12/2019 Duración: 22minMoving Forward in the Treatment of Relapsed/Refractory Follicular Lymphoma: Understanding the PI3K Inhibitors
-
![Debate: Watch and Wait in Follicular Lymphoma or Should We Treat Immediately? - Peter Martin, MD and Carla Casulo, MD]()
Debate: Watch and Wait in Follicular Lymphoma or Should We Treat Immediately? - Peter Martin, MD and Carla Casulo, MD
31/12/2019 Duración: 33minMoving Forward in the Treatment of Relapsed/Refractory Follicular Lymphoma: Understanding the PI3K Inhibitors
-
![Epigenetic Therapy for Lymphoma: From the Laboratory to the Clinic - Ari M. Melnick, MD]()
Epigenetic Therapy for Lymphoma: From the Laboratory to the Clinic - Ari M. Melnick, MD
31/12/2019 Duración: 22minMoving Forward in the Treatment of Relapsed/Refractory Follicular Lymphoma: Understanding the PI3K Inhibitors
-
![Panel Discussion: Hairy Cell Leukemia - Jacqueline C. Barrientos, MD, MS and Jae Park, MD]()
Panel Discussion: Hairy Cell Leukemia - Jacqueline C. Barrientos, MD, MS and Jae Park, MD
31/12/2019 Duración: 16minHairy Cell Leukemia: New and Emerging Agents
